Jan Grimm, MD, PhD

Publications

166

Funding

11 View NIH portfolio on RePORTER ↗

Active

4 grants

PI
Modulating the tumor microenvironment to enhance nanoparticle delivery
NCI · 2026–2031 · via NIH RePORTER
R01CA298818-01A1
PI
Short-wave infrared Cerenkov imaging to better visualize targeted radiotherapy and diagnostic radiotracers
NCI · 2026–2031 · via NIH RePORTER
R01CA313953-01
MPI
PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
NCI · 2021–2027 · via NIH RePORTER
R01CA257811-05
PI
Multicolor PET to interrogate cancer biology
NIBIB · 2023–2027 · via NIH RePORTER
R01EB033000-04

Completed grants (7)

PI
Cerenkov 2.0 – Cerenkov-activated agents for imaging and therapy
NIBIB · 2022–2024 · via NIH RePORTER
R56EB030512-01A1
PI
PET nanoreporter image-guided breast cancer therapy
NCI · 2018–2023 · via NIH RePORTER
R01CA220234-04
PI
Exploring PSMA Biology in Tumor neovasculature
NCI · 2017–2022 · via NIH RePORTER
R01CA212379-05
PI
Exploiting ferroportin for cancer imaging and therapy
NCI · 2017–2022 · via NIH RePORTER
R01CA218615-05
PI
Smart and self-reporting clinical nano carriers for drug delivery
NCI · 2017–2022 · via NIH RePORTER
R01CA215700-05
PI
Cerenkov luminescence imaging for image-guided cancer surgery
NCI · 2015–2020 · via NIH RePORTER
R01CA183953-05
PI
Cerenkov-emission based nanosensors to detect biologic activities in vivo
NIBIB · 2012–2017 · via NIH RePORTER
R01EB014944-04

Mentoring

6 All publications with mentees →

EP
Edwin Pratt
Pharmacology (PhD) · Class of 2020
- A tissue-informed deep learning-based method for positron range correction in preclinical [Formula: see text]Ga PET imaging.
  EJNMMI physics · 2026
- Cerenkov Imaging
  Molecular Imaging Principles and Practice · 2021
- Synthesis of the PET Tracer ¹²⁴I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
View all 9 →
EI
Elizabeth Isaac
Pharmacology (PhD) · Class of 2024
- A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging.
  Nature biomedical engineering · 2024
- A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging.
  Research square · 2024
- Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy.
  ACS nano · 2023
View all 5 →
NP
Ngan Phung
Pharmacology (PhD)
- Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.
  Theranostics · 2025
- A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging.
  Nature biomedical engineering · 2024
- A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging.
  Research square · 2024
View all 5 →
ES
Evan Stater
Pharmacology (PhD) · Class of 2022
- The ancillary effects of nanoparticles and their implications for nanomedicine.
  Nature nanotechnology · 2021
- Synthesis of the PET Tracer ¹²⁴I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
- The Present and Future of Optical Imaging Technologies in the Clinic: Diagnosis and Therapy
  Topics in Medicinal Chemistry · 2020
View all 4 →
EA
Elana Apfelbaum
Pharmacology (PhD)
- In vivo imaging of ferroptosis through nanodynamic changes in lipid membranes.
  bioRxiv : the preprint server for biology · 2024
- A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging.
  Nature biomedical engineering · 2024
- A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging.
  Research square · 2024
View all 3 →
AT
Achmed Turay
Early career mentee · Class of 2018